Background Mavacamten, a selective cardiac myosin inhibitor, is a therapeutic option for hypertrophic cardiomyopathy (HCM). Its impact on exercise capacity, health-related quality of life and left ...
RNA therapeutics have emerged as one of the most promising new classes of medicines. Eight small interfering RNA (siRNA) ...
An actomyosin network (PANEM) forms around the nucleus in prophase, and its contraction repositions peripheral and polar chromosomes to facilitate their interaction with the mitotic spindle, ensuring ...
BACKGROUND: Metabolic disturbances are key contributors to myocardial ischemia-reperfusion (I/R) injury, yet the underlying molecular mechanisms remain largely unclear. RND3, a cytosolic small GTPase ...
Ever since humans began building, they’ve been building up. Throughout the millennia, our constructions have reached higher and higher into the sky, spurred by various motivations: religion, democracy ...
A close-up photo of crystals of two different complexes, one shown in yellow and one in orange, on a grey background. Credit: Yury Torubaev Scientists caught a famous “sandwich” molecule in a rare ...
Irena Asmundson is the Managing Director of Ca. Policy Research Initiative at SIEPR and a former IMF staff member. Opinions expressed in articles and other materials are those of the authors; they do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results